Clinical trial
Analysis of Renal Impairment Characteristics and High-Risk Factors in Patients With Chronic Hepatitis B Receiving Long-Term Oral Nucleos(t)Ide Analogues
NCT07730905 is registered in ClinicalTrials.gov with Foshan Hospital of Traditional Chinese Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Renal Impairment Characteristics and High-Risk Factors in Patients With Chronic Hepatitis B Receiving Long-Term Oral Nucleos(t)Ide Analogues
- Lead sponsor
- Foshan Hospital of Traditional Chinese Medicine
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 4, 2024
- Completion date
- December 31, 2025
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-alcoholic fatty liver disease, renal function impairment